The global HPV Genetically Engineered Vaccine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Bivalent HPV Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of HPV Genetically Engineered Vaccine include Merck & Co., Inc., GSK, Walvax Biotechnology Co.,Ltd., Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Sanofi Pasteur, Serum Institute, Shanghai Zerun Biological Technology Co., Ltd., Shanghai Bovax Biotechnology Co., Ltd. and Beijing Health Guard Biotechnology Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for HPV Genetically Engineered Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Genetically Engineered Vaccine. This report contains market size and forecasts of HPV Genetically Engineered Vaccine in global, including the following market information:
Global HPV Genetically Engineered Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global HPV Genetically Engineered Vaccine Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five HPV Genetically Engineered Vaccine companies in 2023 (%)
We surveyed the HPV Genetically Engineered Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HPV Genetically Engineered Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global HPV Genetically Engineered Vaccine Market Segment Percentages, by Type, 2023 (%)
Bivalent HPV Vaccine
Quadrivalent HPV Vaccine
9-valent HPV Vaccine
Global HPV Genetically Engineered Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global HPV Genetically Engineered Vaccine Market Segment Percentages, by Application, 2023 (%)
Male
Female
Global HPV Genetically Engineered Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global HPV Genetically Engineered Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HPV Genetically Engineered Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies HPV Genetically Engineered Vaccine revenues share in global market, 2023 (%)
Key companies HPV Genetically Engineered Vaccine sales in global market, 2019-2024 (Estimated), (K Units)
Key companies HPV Genetically Engineered Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc.
GSK
Walvax Biotechnology Co.,Ltd.
Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
Sanofi Pasteur
Serum Institute
Shanghai Zerun Biological Technology Co., Ltd.
Shanghai Bovax Biotechnology Co., Ltd.
Beijing Health Guard Biotechnology Inc.
Jiangsu Recbio Technology Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of HPV Genetically Engineered Vaccine, market overview.
Chapter 2: Global HPV Genetically Engineered Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of HPV Genetically Engineered Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HPV Genetically Engineered Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global HPV Genetically Engineered Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HPV Genetically Engineered Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HPV Genetically Engineered Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HPV Genetically Engineered Vaccine Overall Market Size
2.1 Global HPV Genetically Engineered Vaccine Market Size: 2023 VS 2030
2.2 Global HPV Genetically Engineered Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global HPV Genetically Engineered Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top HPV Genetically Engineered Vaccine Players in Global Market
3.2 Top Global HPV Genetically Engineered Vaccine Companies Ranked by Revenue
3.3 Global HPV Genetically Engineered Vaccine Revenue by Companies
3.4 Global HPV Genetically Engineered Vaccine Sales by Companies
3.5 Global HPV Genetically Engineered Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 HPV Genetically Engineered Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers HPV Genetically Engineered Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 HPV Genetically Engineered Vaccine Players in Global Market
3.8.1 List of Global Tier 1 HPV Genetically Engineered Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 HPV Genetically Engineered Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global HPV Genetically Engineered Vaccine Market Size Markets, 2023 & 2030
4.1.2 Bivalent HPV Vaccine
4.1.3 Quadrivalent HPV Vaccine
4.1.4 9-valent HPV Vaccine
4.2 By Type - Global HPV Genetically Engineered Vaccine Revenue & Forecasts
4.2.1 By Type - Global HPV Genetically Engineered Vaccine Revenue, 2019-2024
4.2.2 By Type - Global HPV Genetically Engineered Vaccine Revenue, 2025-2030
4.2.3 By Type - Global HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global HPV Genetically Engineered Vaccine Sales & Forecasts
4.3.1 By Type - Global HPV Genetically Engineered Vaccine Sales, 2019-2024
4.3.2 By Type - Global HPV Genetically Engineered Vaccine Sales, 2025-2030
4.3.3 By Type - Global HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global HPV Genetically Engineered Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HPV Genetically Engineered Vaccine Market Size, 2023 & 2030
5.1.2 Male
5.1.3 Female
5.2 By Application - Global HPV Genetically Engineered Vaccine Revenue & Forecasts
5.2.1 By Application - Global HPV Genetically Engineered Vaccine Revenue, 2019-2024
5.2.2 By Application - Global HPV Genetically Engineered Vaccine Revenue, 2025-2030
5.2.3 By Application - Global HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global HPV Genetically Engineered Vaccine Sales & Forecasts
5.3.1 By Application - Global HPV Genetically Engineered Vaccine Sales, 2019-2024
5.3.2 By Application - Global HPV Genetically Engineered Vaccine Sales, 2025-2030
5.3.3 By Application - Global HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global HPV Genetically Engineered Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global HPV Genetically Engineered Vaccine Market Size, 2023 & 2030
6.2 By Region - Global HPV Genetically Engineered Vaccine Revenue & Forecasts
6.2.1 By Region - Global HPV Genetically Engineered Vaccine Revenue, 2019-2024
6.2.2 By Region - Global HPV Genetically Engineered Vaccine Revenue, 2025-2030
6.2.3 By Region - Global HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global HPV Genetically Engineered Vaccine Sales & Forecasts
6.3.1 By Region - Global HPV Genetically Engineered Vaccine Sales, 2019-2024
6.3.2 By Region - Global HPV Genetically Engineered Vaccine Sales, 2025-2030
6.3.3 By Region - Global HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America HPV Genetically Engineered Vaccine Revenue, 2019-2030
6.4.2 By Country - North America HPV Genetically Engineered Vaccine Sales, 2019-2030
6.4.3 US HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.4.4 Canada HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.4.5 Mexico HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe HPV Genetically Engineered Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe HPV Genetically Engineered Vaccine Sales, 2019-2030
6.5.3 Germany HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.5.4 France HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.5.5 U.K. HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.5.6 Italy HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.5.7 Russia HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.5.9 Benelux HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia HPV Genetically Engineered Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia HPV Genetically Engineered Vaccine Sales, 2019-2030
6.6.3 China HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.6.4 Japan HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.6.5 South Korea HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.6.7 India HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America HPV Genetically Engineered Vaccine Revenue, 2019-2030
6.7.2 By Country - South America HPV Genetically Engineered Vaccine Sales, 2019-2030
6.7.3 Brazil HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.7.4 Argentina HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa HPV Genetically Engineered Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa HPV Genetically Engineered Vaccine Sales, 2019-2030
6.8.3 Turkey HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.8.4 Israel HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia HPV Genetically Engineered Vaccine Market Size, 2019-2030
6.8.6 UAE HPV Genetically Engineered Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Company Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. HPV Genetically Engineered Vaccine Major Product Offerings
7.1.4 Merck & Co., Inc. HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 Merck & Co., Inc. Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK HPV Genetically Engineered Vaccine Major Product Offerings
7.2.4 GSK HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 GSK Key News & Latest Developments
7.3 Walvax Biotechnology Co.,Ltd.
7.3.1 Walvax Biotechnology Co.,Ltd. Company Summary
7.3.2 Walvax Biotechnology Co.,Ltd. Business Overview
7.3.3 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Major Product Offerings
7.3.4 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 Walvax Biotechnology Co.,Ltd. Key News & Latest Developments
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Summary
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Business Overview
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Major Product Offerings
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Key News & Latest Developments
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Company Summary
7.5.2 Sanofi Pasteur Business Overview
7.5.3 Sanofi Pasteur HPV Genetically Engineered Vaccine Major Product Offerings
7.5.4 Sanofi Pasteur HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Pasteur Key News & Latest Developments
7.6 Serum Institute
7.6.1 Serum Institute Company Summary
7.6.2 Serum Institute Business Overview
7.6.3 Serum Institute HPV Genetically Engineered Vaccine Major Product Offerings
7.6.4 Serum Institute HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Serum Institute Key News & Latest Developments
7.7 Shanghai Zerun Biological Technology Co., Ltd.
7.7.1 Shanghai Zerun Biological Technology Co., Ltd. Company Summary
7.7.2 Shanghai Zerun Biological Technology Co., Ltd. Business Overview
7.7.3 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Major Product Offerings
7.7.4 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Shanghai Zerun Biological Technology Co., Ltd. Key News & Latest Developments
7.8 Shanghai Bovax Biotechnology Co., Ltd.
7.8.1 Shanghai Bovax Biotechnology Co., Ltd. Company Summary
7.8.2 Shanghai Bovax Biotechnology Co., Ltd. Business Overview
7.8.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Major Product Offerings
7.8.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.8.5 Shanghai Bovax Biotechnology Co., Ltd. Key News & Latest Developments
7.9 Beijing Health Guard Biotechnology Inc.
7.9.1 Beijing Health Guard Biotechnology Inc. Company Summary
7.9.2 Beijing Health Guard Biotechnology Inc. Business Overview
7.9.3 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Major Product Offerings
7.9.4 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.9.5 Beijing Health Guard Biotechnology Inc. Key News & Latest Developments
7.10 Jiangsu Recbio Technology Co., Ltd.
7.10.1 Jiangsu Recbio Technology Co., Ltd. Company Summary
7.10.2 Jiangsu Recbio Technology Co., Ltd. Business Overview
7.10.3 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Major Product Offerings
7.10.4 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.10.5 Jiangsu Recbio Technology Co., Ltd. Key News & Latest Developments
8 Global HPV Genetically Engineered Vaccine Production Capacity, Analysis
8.1 Global HPV Genetically Engineered Vaccine Production Capacity, 2019-2030
8.2 HPV Genetically Engineered Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global HPV Genetically Engineered Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HPV Genetically Engineered Vaccine Supply Chain Analysis
10.1 HPV Genetically Engineered Vaccine Industry Value Chain
10.2 HPV Genetically Engineered Vaccine Upstream Market
10.3 HPV Genetically Engineered Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 HPV Genetically Engineered Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of HPV Genetically Engineered Vaccine in Global Market
Table 2. Top HPV Genetically Engineered Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global HPV Genetically Engineered Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global HPV Genetically Engineered Vaccine Revenue Share by Companies, 2019-2024
Table 5. Global HPV Genetically Engineered Vaccine Sales by Companies, (K Units), 2019-2024
Table 6. Global HPV Genetically Engineered Vaccine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers HPV Genetically Engineered Vaccine Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers HPV Genetically Engineered Vaccine Product Type
Table 9. List of Global Tier 1 HPV Genetically Engineered Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HPV Genetically Engineered Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global HPV Genetically Engineered Vaccine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global HPV Genetically Engineered Vaccine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global HPV Genetically Engineered Vaccine Sales (K Units), 2019-2024
Table 15. By Type - Global HPV Genetically Engineered Vaccine Sales (K Units), 2025-2030
Table 16. By Application ? Global HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global HPV Genetically Engineered Vaccine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global HPV Genetically Engineered Vaccine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global HPV Genetically Engineered Vaccine Sales (K Units), 2019-2024
Table 20. By Application - Global HPV Genetically Engineered Vaccine Sales (K Units), 2025-2030
Table 21. By Region ? Global HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global HPV Genetically Engineered Vaccine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global HPV Genetically Engineered Vaccine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global HPV Genetically Engineered Vaccine Sales (K Units), 2019-2024
Table 25. By Region - Global HPV Genetically Engineered Vaccine Sales (K Units), 2025-2030
Table 26. By Country - North America HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America HPV Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 29. By Country - North America HPV Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 30. By Country - Europe HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe HPV Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 33. By Country - Europe HPV Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 34. By Region - Asia HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia HPV Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 37. By Region - Asia HPV Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 38. By Country - South America HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America HPV Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 41. By Country - South America HPV Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa HPV Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa HPV Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. HPV Genetically Engineered Vaccine Product Offerings
Table 48. Merck & Co., Inc. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck & Co., Inc. Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK HPV Genetically Engineered Vaccine Product Offerings
Table 52. GSK HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. GSK Key News & Latest Developments
Table 54. Walvax Biotechnology Co.,Ltd. Company Summary
Table 55. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product Offerings
Table 56. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Walvax Biotechnology Co.,Ltd. Key News & Latest Developments
Table 58. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Summary
Table 59. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product Offerings
Table 60. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Key News & Latest Developments
Table 62. Sanofi Pasteur Company Summary
Table 63. Sanofi Pasteur HPV Genetically Engineered Vaccine Product Offerings
Table 64. Sanofi Pasteur HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Sanofi Pasteur Key News & Latest Developments
Table 66. Serum Institute Company Summary
Table 67. Serum Institute HPV Genetically Engineered Vaccine Product Offerings
Table 68. Serum Institute HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Serum Institute Key News & Latest Developments
Table 70. Shanghai Zerun Biological Technology Co., Ltd. Company Summary
Table 71. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product Offerings
Table 72. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Shanghai Zerun Biological Technology Co., Ltd. Key News & Latest Developments
Table 74. Shanghai Bovax Biotechnology Co., Ltd. Company Summary
Table 75. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product Offerings
Table 76. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Shanghai Bovax Biotechnology Co., Ltd. Key News & Latest Developments
Table 78. Beijing Health Guard Biotechnology Inc. Company Summary
Table 79. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product Offerings
Table 80. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Beijing Health Guard Biotechnology Inc. Key News & Latest Developments
Table 82. Jiangsu Recbio Technology Co., Ltd. Company Summary
Table 83. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product Offerings
Table 84. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Jiangsu Recbio Technology Co., Ltd. Key News & Latest Developments
Table 86. HPV Genetically Engineered Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 87. Global HPV Genetically Engineered Vaccine Capacity Market Share of Key Manufacturers, 2021-2024
Table 88. Global HPV Genetically Engineered Vaccine Production by Region, 2019-2024 (K Units)
Table 89. Global HPV Genetically Engineered Vaccine Production by Region, 2025-2030 (K Units)
Table 90. HPV Genetically Engineered Vaccine Market Opportunities & Trends in Global Market
Table 91. HPV Genetically Engineered Vaccine Market Drivers in Global Market
Table 92. HPV Genetically Engineered Vaccine Market Restraints in Global Market
Table 93. HPV Genetically Engineered Vaccine Raw Materials
Table 94. HPV Genetically Engineered Vaccine Raw Materials Suppliers in Global Market
Table 95. Typical HPV Genetically Engineered Vaccine Downstream
Table 96. HPV Genetically Engineered Vaccine Downstream Clients in Global Market
Table 97. HPV Genetically Engineered Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. HPV Genetically Engineered Vaccine Segment by Type in 2023
Figure 2. HPV Genetically Engineered Vaccine Segment by Application in 2023
Figure 3. Global HPV Genetically Engineered Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global HPV Genetically Engineered Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global HPV Genetically Engineered Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. HPV Genetically Engineered Vaccine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by HPV Genetically Engineered Vaccine Revenue in 2023
Figure 9. By Type - Global HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 11. By Type - Global HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 12. By Type - Global HPV Genetically Engineered Vaccine Price (US$/Unit), 2019-2030
Figure 13. By Application - Global HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 15. By Application - Global HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 16. By Application - Global HPV Genetically Engineered Vaccine Price (US$/Unit), 2019-2030
Figure 17. By Region - Global HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global HPV Genetically Engineered Vaccine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 20. By Region - Global HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 21. By Country - North America HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 22. By Country - North America HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 23. US HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 28. Germany HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. France HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 37. China HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. India HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 43. By Country - South America HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 44. Brazil HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa HPV Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa HPV Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 48. Turkey HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE HPV Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 52. Global HPV Genetically Engineered Vaccine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production HPV Genetically Engineered Vaccine by Region, 2023 VS 2030
Figure 54. HPV Genetically Engineered Vaccine Industry Value Chain
Figure 55. Marketing Channels
